Literature DB >> 23059484

Type A behavior pattern: is it a risk factor for open-angle chronic glaucoma?

Raffaella Morreale Bubella1, Daniele Morreale Bubella, Salvatore Cillino.   

Abstract

AIM: : To evaluate the presence of type A behavior in patients affected by open-angle glaucoma (OAG) and the possible role of psychophysiological stress as a risk factor for OAG.
MATERIALS AND METHODS: Fifty patients, 30 women and 20 men, affected by OAG, underwent ophthalmological examination consisting of complete biomicroscopy, tonometry and daily tonometric curve, examination of the visual field by means of computerized perimeter "Octopus 1-2-3," and its assessment with the Glaucoma Staging System 2, morphologic monitoring of the retinal nerve fiber layer with GDx VCC and psychological assessment (Hamilton Anxiety Rating Scale) to evaluate the presence of anxiety and its level; type A/B personality questionnaire (Jenkin Modified Activity Survey; Ercta-B test for the further evaluation of type A personality; STAY test; Brief-cope test; Life event.
RESULTS: Sixty-four percent of the subjects, 17 women and 13 men, showed type A behavior, and in these patients both trait and state anxiety were much more evident (P=0.001). In the type A subjects, there was a much more significant visual field involvement (P=0.001); this involvement showed a negative correlation (P=0.024) with the Brief-cope scale.
CONCLUSIONS: The personality study is an extremely important part of the diagnostic work-up and treatment of OAG.

Entities:  

Mesh:

Year:  2014        PMID: 23059484     DOI: 10.1097/IJG.0b013e3182707421

Source DB:  PubMed          Journal:  J Glaucoma        ISSN: 1057-0829            Impact factor:   2.503


  9 in total

Review 1.  Mental stress as consequence and cause of vision loss: the dawn of psychosomatic ophthalmology for preventive and personalized medicine.

Authors:  Bernhard A Sabel; Jiaqi Wang; Lizbeth Cárdenas-Morales; Muneeb Faiq; Christine Heim
Journal:  EPMA J       Date:  2018-05-09       Impact factor: 6.543

2.  The temperament and character personality profile of the glaucoma patient.

Authors:  Harun Çakmak; Vesile Altinyazar; Suzan Güven Yilmaz; İmran Kurt Ömürlü; Tolga Kocatürk; Alper Yazici; Cumali Değirmenci; Sema Oruç Dündar; Halil Ates
Journal:  BMC Ophthalmol       Date:  2015-10-01       Impact factor: 2.209

3.  Association between zolpidem use and glaucoma risk: a Taiwanese population-based case-control study.

Authors:  Yi-Hao Ho; Yue-Cune Chang; Wei-Cheng Huang; Hsin-Yi Chen; Che-Chen Lin; Fung-Chang Sung
Journal:  J Epidemiol       Date:  2014-08-23       Impact factor: 3.211

4.  Comment on "Short-term effects of relaxation music on patients suffering from primary open-angle glaucoma".

Authors:  Abdullah Kaya; Yakup Aksoy; Mehmet Koray Sevinç; Oktay Diner
Journal:  Clin Ophthalmol       Date:  2015-12-11

5.  Relationship between type A behavior patterns and risk of temporomandibular disorder in Japanese undergraduate students.

Authors:  Hiroki Ohmi; Mariko Kato; Martin Meadows
Journal:  J Rural Med       Date:  2016-12-01

6.  Acute emotional stress as a trigger for intraocular pressure elevation in Glaucoma.

Authors:  Kevin Gillmann; Kirsten Hoskens; Kaweh Mansouri
Journal:  BMC Ophthalmol       Date:  2019-03-08       Impact factor: 2.209

7.  The effect of daily life activities on intraocular pressure related variations in open-angle glaucoma.

Authors:  Kevin Gillmann; Robert N Weinreb; Kaweh Mansouri
Journal:  Sci Rep       Date:  2021-03-23       Impact factor: 4.379

8.  Personality types of patients with glaucoma: A systematic review of observational studies.

Authors:  Zhenyan Tan; Tao-Hsin Tung; Shi-Qing Xu; Pei-En Chen; Ching-Wen Chien; Bo Jiang
Journal:  Medicine (Baltimore)       Date:  2021-06-11       Impact factor: 1.817

9.  Illness uncertainty, anxiety and depression in Chinese patients with glaucoma or cataract.

Authors:  Dandan Zhang; Zhigang Fan; Xinbo Gao; Wenmin Huang; Qiongman Yang; Zhongwen Li; Mingkai Lin; Huiming Xiao; Jian Ge
Journal:  Sci Rep       Date:  2018-08-03       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.